Ellevest, Inc. Takeda Pharmaceutical CO LTD Transaction History

Ellevest, Inc.

$677 Million
Q3 2025

A detailed history of Ellevest, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ellevest, Inc. holds 48,573 shares of TAK stock, worth $694,108. This represents 0.1% of its overall portfolio holdings.

Number of Shares

48,573

Previous 42,949 13.09%

Holding current value

$694,108

Previous $663,000 7.24%

% of portfolio

0.1%

Previous 0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$13.6 - $15.52 $76,486 - $87,284	5,624 Added 13.09%	48,573 $711,000
Q2 2025 Aug 05, 2025	BUY	$13.71 - $15.46 $200,330 - $225,901	14,612 Added 51.57%	42,949 $663,000
Q1 2025 May 14, 2025	SELL	$12.89 - $15.19 $155,221 - $182,917	-12,042 Reduced 29.82%	28,337 $421,000
Q4 2024 Feb 14, 2025	SELL	$13.01 - $14.43 $501,522 - $556,262	-38,549 Reduced 48.84%	40,379 $534,000
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $296,985 - $344,502	22,845 Added 40.73%	78,928 $1.12 Million

Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $279,165 - $302,872	-22,156 Reduced 28.32%	56,083 $725,000
Q1 2024 May 13, 2024	BUY	$13.89 - $15.04 $205,766 - $222,802	14,814 Added 23.36%	78,239 $1.09 Million
Q4 2023 Feb 06, 2024	SELL	$13.36 - $15.43 $175,764 - $202,997	-13,156 Reduced 17.18%	63,425 $905,000
Q3 2023 Nov 09, 2023	BUY	$15.03 - $16.32 $369,858 - $401,602	24,608 Added 47.35%	76,581 $1.18 Million
Q2 2023 Aug 09, 2023	BUY	$15.57 - $17.11 $149,767 - $164,581	9,619 Added 22.71%	51,973 $816,000
Q1 2023 May 04, 2023	BUY	$15.28 - $16.48 $205,531 - $221,672	13,451 Added 46.54%	42,354 $697,000
Q4 2022 Feb 03, 2023	BUY	$12.42 - $15.62 $261,441 - $328,801	21,050 Added 268.05%	28,903 $451,000
Q3 2022 Nov 02, 2022	SELL	$12.8 - $28.65 $75,110 - $168,118	-5,868 Reduced 42.77%	7,853 $102,000
Q2 2022 Jul 18, 2022	SELL	$13.12 - $15.03 $226,503 - $259,477	-17,264 Reduced 55.72%	13,721 $193,000
Q1 2022 Apr 19, 2022	BUY	$13.54 - $15.35 $83,311 - $94,448	6,153 Added 24.78%	30,985 $444,000
Q4 2021 Jan 24, 2022	BUY	$13.17 - $16.4 $26,445 - $32,931	2,008 Added 8.8%	24,832 $338,000
Q3 2021 Oct 19, 2021	BUY	$16.3 - $17.26 $119,805 - $126,861	7,350 Added 47.5%	22,824 $374,000
Q2 2021 Jul 13, 2021	BUY	$16.55 - $18.64 $4,832 - $5,442	292 Added 1.92%	15,474 $260,000
Q1 2021 May 03, 2021	BUY	$16.71 - $19.9 $78,921 - $93,987	4,723 Added 45.16%	15,182 $277,000
Q4 2020 Feb 04, 2021	BUY	$15.39 - $18.97 $29,594 - $36,479	1,923 Added 22.53%	10,459 $190,000
Q3 2020 Oct 26, 2020	BUY	$17.1 - $19.19 $40,390 - $45,326	2,362 Added 38.26%	8,536 $152,000
Q2 2020 Jul 06, 2020	BUY	$14.59 - $19.5 $43,624 - $58,305	2,990 Added 93.91%	6,174 $111,000
Q1 2020 Apr 13, 2020	BUY	$13.02 - $20.31 $20,324 - $31,703	1,561 Added 96.18%	3,184 $48,000
Q4 2019 Feb 05, 2020	BUY	$16.88 - $20.83 $27,396 - $33,807	1,623 New	1,623 $32,000

Others Institutions Holding TAK

# of Institutions

384

Shares Held

80.7M

Call Options Held

1.67M

Put Options Held

276K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account